Hydroxystilbene compounds for reducing/inhibiting protein glycation

A regime and/or regimen for reducing or inhibiting the glycation of proteins of an individual subject in need of such treatment, comprising administering to such subject an effective amount of at least one hydroxystilbene compound, for such period of time as required to elicit reduction or inhibition of the glycation of the proteins, said period of time being at least 3 to 8 weeks.

A regime and/or regimen for reducing or inhibiting the glycation of susceptible proteins of the skin of an individual subject in need of such treatment, comprising topically administering to such subject an effective amount of at least one hydroxystilbene compound, for such period of time as required to elicit reduction or inhibition of the glycation of the susceptible proteins of the skin, said period of time being at least 3 to 8 weeks.

A regime and/or regimen for reducing or inhibiting the glycation of susceptible substrates of an individual subject in need of such treatment, comprising administering to such subject an effective amount of at least one hydroxystilbene compound, for such period of time as required to elicit reduction or inhibition of the glycation of the susceptible substrates, said period of time being at least 3 to 8 weeks, with the proviso that when said regime and/or regimen is for treating signs of aging of the skin, said signs are those resulting from glycation of collagen in the dermis.

A regime and/or regimen for reducing or inhdibiting the glycation of proteins of an individual subject in need of such treatment, comprising administering to such subject an effective amount of at least one hydroxystilbene compound, for such period of time as required to elicit reduction or inhibition of the glycation of the proteins, said period of time being at least 3 to 8 weeks, with the proviso that when said regime and/or regimen is for treating signs of aging of the skin, said signs are those resulting from glycation of collagen in the dermis.

A regime and/or regimen for reducing or inhibiting the glycation of susceptible proteins of the skin of an individual subject in need of such treatment, comprising topically administering to such subject an effective amount of at least one hydroxystilbene compound, for such period of time as required to elicit reduction or inhibition of the glycation of the susceptible proteins of the skin, said period of time being at least 3 to 8 weeks, with the proviso that when said regime and/or regimen is for treating signs of aging of the skin, said signs are those resulting from glycation of collagen in the dermis.